Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CHEMOSITE IMPLANTABLE DRUG DELIVERY SYSTEM

K-Number: K904417 · 1990-12-05

ApplicantDevice Labs, Inc.
Decision Date1990-12-05
Product CodeLJT
Advisory CommitteeHO
DecisionSubstantially Equivalent

Device Summary

CHEMOSITE IMPLANTABLE DRUG DELIVERY SYSTEM is the device name listed in this FDA 510(k) record. The listed applicant is Device Labs, Inc.. It received FDA 510(k) clearance on 1990-12-05 under 510(k) number K904417. The device is classified under product code LJT. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CHEMOSITE IMPLANTABLE DRUG DELIVERY SYSTEM?

CHEMOSITE IMPLANTABLE DRUG DELIVERY SYSTEM is a medical device that received FDA 510(k) clearance on 1990-12-05. The listed applicant is Device Labs, Inc.. The 510(k) number is K904417.

When did CHEMOSITE IMPLANTABLE DRUG DELIVERY SYSTEM receive FDA 510(k) clearance?

CHEMOSITE IMPLANTABLE DRUG DELIVERY SYSTEM received FDA 510(k) clearance on 1990-12-05, under 510(k) number K904417.

Who is the listed applicant for CHEMOSITE IMPLANTABLE DRUG DELIVERY SYSTEM?

The FDA 510(k) record lists Device Labs, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CHEMOSITE IMPLANTABLE DRUG DELIVERY SYSTEM?

The FDA product code for CHEMOSITE IMPLANTABLE DRUG DELIVERY SYSTEM is LJT.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Device Labs, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K930632CHEMOSITE IMPLANTABLE DRUG DELIVERYK902135PERCUTANEOUS INTRODUCER KITK901722CHEMOSITE(TM) IMPLANTABLE DRUG DELIVERY SYSTEMK883764INTRAVASCULAR ADMINISTRATION SETK882064LO-CORE NEEDLE

Related Devices (Code: LJT)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K260916FLEXI-PORT™ Power Injectable Implantable PortPortal Access, Inc.K252478Vaccess™ CT Low-Profile Power-Injectable Implantable Port; Vaccess™ CT Power-Injectable Implantable Port; PowerPort™ duo M.R.I. ™ Implantable PortBard Access Systems, Inc.K251253PowerPort™ isp Implantable Port; PowerPort™ Slim Implantable Port; PowerPort™ M.R.I. ™ Implantable Port; PowerPort™ M.R.I.™ isp Implantable PortBard Access Systems, Inc.K242328PowerPort™ ClearVUE™ Slim Implantable Ports and PowerPort™ ClearVUE™ Slim Implantable PortsBard Access Systems, Inc.K232737PowerPort™ ClearVUE™ Slim ECG Enabled Implantable Port; PowerPort™ ClearVUE™ isp ECG Enabled Implantable Port; PowerPort™ isp M.R.I.™ ECG Enabled Implantable Port; PowerPort™ Slim ECG Enabled Implantable PortBard Peripheral Vascular, Inc.K190559SmartPort+ Implantable Ports, SmartPort Plastic Implantable PortsAngioDynamics, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑